Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:impotence
go back to main search page
Accession:DOID:1875 term browser browse the term
Definition:The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
Synonyms:exact_synonym: Male Impotence;   erectile dysfunction;   male sexual impotence;   sexual impotence
 primary_id: MESH:D007172
 alt_id: RDO:0005882
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants           Sort by:
 
impotence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ager advanced glycosylation end product-specific receptor treatment IDA associated with Diabetes Mellitus, Experimental RGD PMID:23698784 RGD:7244246 NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079 		JBrowse link
G Agt angiotensinogen treatment IDA RGD PMID:17616753 RGD:8548892 NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 treatment IDA associated with Diabetes Mellitus, Experimental RGD PMID:21235725 RGD:10053666 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G Bad BCL2-associated agonist of cell death treatment IDA associated with Diabetes Mellitus, Experimental RGD PMID:21235725 RGD:10053666 NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator treatment IEP associated with Diabetes Mellitus, Experimental RGD PMID:21235725 RGD:10053666 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Bcl2 BCL2, apoptosis regulator treatment IDA
ISO
IEP		 CTD Direct Evidence: marker/mechanism
associated with Diabetes Mellitus, Experimental		 CTD PMID:12394778, PMID:12394778, PMID:21235725 RGD:1579980, RGD:10053666 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374 		JBrowse link
G Bcl2l1 Bcl2-like 1 IDA
ISO		 CTD Direct Evidence: marker/mechanism CTD PMID:12394778, PMID:12394778 RGD:1579980 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810 		JBrowse link
G Casp3 caspase 3 treatment IEP associated with Diabetes Mellitus, Experimental RGD PMID:21235725 RGD:10053666 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Ccnd1 cyclin D1 IEP mRNA:decreased expression:penis erectile tissue RGD PMID:17137605 RGD:1625408 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325 		JBrowse link
G Ccnd2 cyclin D2 IEP associated with Diabetes Mellitus, Experimental;mRNA:decreased expression:penis RGD PMID:18068478 RGD:2289159 NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207 		JBrowse link
G Cfl1 cofilin 1 treatment IEP protein:increased phosphorylation:corpus cavernosum penis (rat) RGD PMID:25923835, PMID:25444982 RGD:11568706, RGD:11570410 NCBI chr 1:220,869,805...220,873,337
Ensembl chr 1:220,869,805...220,873,337 		JBrowse link
G Cnr1 cannabinoid receptor 1 IMP associated with Diabetes Mellitus, Experimental RGD PMID:17850365 RGD:2314634 NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056 		JBrowse link
G Dynll1 dynein light chain LC8-type 1 treatment IMP RGD PMID:17433082 RGD:13207433 NCBI chr12:47,074,200...47,076,573
Ensembl chr12:47,074,200...47,076,572 		JBrowse link
G Edn1 endothelin 1 IEP
ISO		 protein:increased expression:plasma
CTD Direct Evidence: marker/mechanism		 CTD PMID:12002441, PMID:17420087 RGD:2292142 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324 		JBrowse link
G Ednra endothelin receptor type A IEP
ISO		 CTD Direct Evidence: marker/mechanism CTD PMID:18823320, PMID:17420087 RGD:2292142 NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703 		JBrowse link
G Fabp4 fatty acid binding protein 4 IEP associated with hypercholesterolemia;mRNA:increased expression:penis erectile tissue RGD PMID:17137605 RGD:1625408 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305 		JBrowse link
G Fgf2 fibroblast growth factor 2 ISO associated with Diabetes Mellitus, Experimental RGD PMID:15758817 RGD:2315866 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681 		JBrowse link
G Gja1 gap junction protein, alpha 1 IEP mRNA, protein:decreased expression:corpus cavernosum penis RGD PMID:17146929 RGD:8662385 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089 		JBrowse link
G Grin3a glutamate ionotropic receptor NMDA type subunit 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19295509 NCBI chr 5:64,928,620...65,073,012
Ensembl chr 5:64,928,620...65,073,012 		JBrowse link
G Grk2 G protein-coupled receptor kinase 2 IMP associated with Diabetes Mellitus, Experimental RGD PMID:30226217 RGD:13792691 NCBI chr 1:219,536,220...219,544,329
Ensembl chr 1:219,536,220...219,544,328 		JBrowse link
G Hdac3 histone deacetylase 3 IEP protein:increased expression:penis: RGD PMID:24636283 RGD:9590194 NCBI chr18:31,073,057...31,094,347
Ensembl chr18:31,073,058...31,094,303 		JBrowse link
G Hdac4 histone deacetylase 4 ISO protein:increased expression:penis: RGD PMID:24636283 RGD:9590194 NCBI chr 9:99,052,945...99,299,715
Ensembl chr 9:99,057,089...99,299,715 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 treatment IMP
IEP		 mRNA, protein:increased expression:penis RGD PMID:24576658, PMID:21595839 RGD:10402763, RGD:10402765 NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374 		JBrowse link
G Il6 interleukin 6 treatment IMP
IEP		 associated with Diabetes Mellitus, Type 2 RGD PMID:21492407, PMID:24467772 RGD:10402827, RGD:9495931 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Kdr kinase insert domain receptor IEP RGD PMID:16422887 RGD:5684417 NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183 		JBrowse link
G Mcam melanoma cell adhesion molecule IEP protein:decreased expression:penis erectile tissue RGD PMID:24023647 RGD:7364777 NCBI chr 8:48,472,824...48,481,005
Ensembl chr 8:48,472,824...48,481,001 		JBrowse link
G Nos1 nitric oxide synthase 1 treatment IDA
IEP		 associated with Diabetes Mellitus, Experimental
associated with Urethral Obstruction;protein:decreased expression:penis erectile tissue		 RGD PMID:23698784, PMID:23522997, PMID:23535456 RGD:7244246, RGD:7257657, RGD:7257656 NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341 		JBrowse link
G Nos2 nitric oxide synthase 2 IEP associated with Diabetes Mellitus, Experimental;protein:increased expression:penis RGD PMID:19554009 RGD:2313212 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190 		JBrowse link
G Nos3 nitric oxide synthase 3 treatment IEP
ISO		 associated with Cocaine-Related Disorders;protein:decreased expression:penis
CTD Direct Evidence: marker/mechanism|therapeutic
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:decreased expression, decreased activity		 CTD PMID:12002441 PMID:17071732, PMID:17420087, PMID:29260891, PMID:20807325 RGD:2292142, RGD:13504711, RGD:4891999 NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410 		JBrowse link
G P2ry1 purinergic receptor P2Y1 IDA associated with Diabetes Mellitus, Experimental RGD PMID:19303093 RGD:2315809 NCBI chr 2:151,314,818...151,320,312
Ensembl chr 2:151,314,818...151,320,319 		JBrowse link
G P2ry2 purinergic receptor P2Y2 IDA associated with Diabetes Mellitus, Experimental RGD PMID:19303093 RGD:2315809 NCBI chr 1:166,031,228...166,045,423
Ensembl chr 1:166,031,272...166,037,424 		JBrowse link
G Pde5a phosphodiesterase 5A IMP associated with Hypercholesterolemia
associated with Diabetes Mellitus, Experimental		 RGD PMID:15920460, PMID:15578039, PMID:15667904 RGD:2314519, RGD:2314521, RGD:2314520 NCBI chr 2:226,899,604...227,044,916
Ensembl chr 2:226,900,619...227,041,576 		JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 IEP associated with Diabetes Mellitus, Experimental;protein:decreased expression:penis erectile tissue RGD PMID:17355372 RGD:7775062 NCBI chr 1:248,982,039...250,300,952 JBrowse link
G Prl prolactin ISO CTD Direct Evidence: marker/mechanism CTD PMID:387166 PMID:4001434 PMID:7878608 PMID:8845563 PMID:15829128 NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299 		JBrowse link
G Shbg sex hormone binding globulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:17961146 NCBI chr10:56,219,861...56,237,354
Ensembl chr10:56,219,858...56,223,245 		JBrowse link
G Sirt1 sirtuin 1 treatment IEP associated with Diabetes Mellitus, Type 2 RGD PMID:24467772 RGD:9495931 NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 IEP associated with Diabetes Mellitus, Experimental;protein:increased expression:penis RGD PMID:18778311, PMID:27051243 RGD:2306738, RGD:14995446 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199 		JBrowse link
G Thbd thrombomodulin ISO associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma RGD PMID:11596671 RGD:2312459 NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325 		JBrowse link
G Tnf tumor necrosis factor treatment IEP associated with Diabetes Mellitus, Type 2 RGD PMID:24467772 RGD:9495931 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
G Vegfa vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12002441 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681 		JBrowse link
G Vip vasoactive intestinal peptide ISO CTD Direct Evidence: therapeutic CTD PMID:10233493 NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582 		JBrowse link
G Xrcc1 X-ray repair cross complementing 1 susceptibility ISO associated with Prostatic Neoplasms;DNA:polymorphism: :p.R280H RGD PMID:18582155 RGD:2302570 NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678 		JBrowse link
vasculogenic impotence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Angpt2 angiopoietin 2 IEP associated with Hypercholesterolemia; mRNA, protein:decreased expression:cavernous body of penis (rat) RGD PMID:16750245 RGD:2314210 NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195 		JBrowse link
G Apod apolipoprotein D IEP mRNA:increased expression:penis erectile tissue RGD PMID:11444882 RGD:2311196 NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301 		JBrowse link
G Pde5a phosphodiesterase 5A IMP RGD PMID:17287493 RGD:2314469 NCBI chr 2:226,899,604...227,044,916
Ensembl chr 2:226,900,619...227,041,576 		JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 ISO protein:increased expression:penis erectile tissue RGD PMID:14718046 RGD:1601627 NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  disease 16122
    disease of anatomical entity 15369
      reproductive system disease 2589
        male reproductive system disease 1774
          sexual dysfunction 48
            impotence 45
              vasculogenic impotence 4
Path 2
Term Annotations click to browse term
  disease 16122
    disease of anatomical entity 15369
      nervous system disease 10977
        central nervous system disease 9099
          brain disease 8407
            disease of mental health 5991
              sexual disorder 53
                sexual dysfunction 48
                  impotence 45
                    vasculogenic impotence 4
paths to the root